AZSTARYS pharmaceutical API fine chemical sources

Subscribe to access the full database, or Get Started Free
Vendor	Vendor Homepage	Vendor Sku	API Url
Starshine Chemical	⤷ Get Started Free	2023-05-9C01243	⤷ Get Started Free
>Vendor	>Vendor Homepage	>Vendor Sku	>API Url

Last updated: July 29, 2025

Introduction

Azstarys® (serdexmethylphenidate and dexmethylphenidate) is a prescription medication approved for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children aged six and above. As a combination of a prodrug (serdexmethylphenidate) and an active form (dextmethylphenidate), Azstarys offers a unique pharmacokinetic profile designed to provide extended therapy with once-daily dosing.

The manufacturing of Azstarys relies on the procurement of its primary active pharmaceutical ingredients (APIs): serdexmethylphenidate and dexmethylphenidate. Ensuring a reliable supply chain of high-quality APIs is critical for manufacturers to meet regulatory standards, maintain consistent product quality, and satisfy market demand.

This article explores the global landscape of API sourcing for Azstarys, highlighting key suppliers, quality considerations, regulatory dynamics, and strategic sourcing insights.

Overview of Active Pharmaceutical Ingredients (APIs) for Azstarys

Serdexmethylphenidate

Serdexmethylphenidate is a prodrug of dexmethylphenidate designed to provide sustained release. It is synthesized through a proprietary process involving methylphenidate derivatives. Its pharmacological activation relies on enzymatic conversion once administered.

Dextmethylphenidate (d-MPH)

Dextmethylphenidate is the active enantiomer of methylphenidate, responsible for the therapeutic effect in ADHD management. Commercially, it is produced as a highly purified chiral compound, adhering strictly to pharmacopeial standards.

Global API Manufacturing Landscape

Major API Producers

The production of APIs such as serdexmethylphenidate and dexmethylphenidate is geographically concentrated in regions with established pharmaceutical manufacturing infrastructure. Key players include:

United States
Several US-based companies possess advanced facilities capable of producing high-purity APIs under strict cGMP conditions. Companies like MilliporeSigma (Merck) and West-Ward Pharmaceuticals have robust API manufacturing capabilities that may supply or partner in API synthesis.
India
India remains a dominant hub for API manufacturing, accounting for over 50% of the world's APIs, according to the India brand report (2022). Firms such as Dr. Reddy’s Laboratories, Aurobindo Pharma, and Sun Pharmaceutical Industries are known for their API quality and cost competitiveness.
China
Chinese API manufacturers, including Zhejiang Xinhua Pharmaceutical, Zhejiang Hisun Pharmaceutical, and Huadong Medicine, produce a spectrum of CNS APIs, including methylphenidate derivatives. Chinese APIs are often utilized globally due to cost efficiencies and expanding capacity.
European Union
While less dominant in API manufacturing compared to India and China, several EU-based companies, such as Synthesis and Fareva, are involved in high-quality API synthesis, especially for regulated markets.

Key API Suppliers for Azstarys

1. Domestic (U.S.) API Suppliers

MilliporeSigma (MERCK)
A leader in pharmaceutical ingredients, provides GMP-grade API manufacturing, including methylphenidate derivatives. Their presence ensures compliance with FDA standards, essential for US-based product approvals.
Bachem
A Swiss company specializing in peptide synthesis, Bachem produces high-quality APIs for CNS indications, including methylphenidate enantiomers. Bachem's facilities are cGMP-certified, offering potential for sourcing high-purity APIs.

2. Indian API Manufacturers

Aurobindo Pharma
Known for robust R&D and manufacturing capabilities, Aurobindo produces methylphenidate APIs meeting international standards.
Hetero Labs
Hetero offers methylphenidate APIs for generic formulations, with multiple manufacturing sites adhering to strict quality norms.
Dr. Reddy’s Laboratories
Their methylphenidate API is used in various ADHD medications, with supply agreements in place for global markets.

3. Chinese API Manufacturers

Zhejiang Xinhua Pharmaceutical
Supplies methylphenidate APIs compliant with industry standards, serving both domestic and export markets.
Zhejiang Hisun Pharmaceutical
Offers methylphenidate enantiomers with GMP certification, often engaged in joint ventures with Western firms.

4. Contract Manufacturing and ODM Partners

Recipharm
Provides custom synthesis services for methylphenidate APIs, enabling smaller batch production for niche applications.
Fareva
Engaged in high-volume API synthesis, ensuring supply continuity for large-scale pharmaceutical productions.

Quality Control and Regulatory Considerations

Ensuring API quality is imperative for pharmaceutical compliance, safety, and efficacy. The primary standards include:

Good Manufacturing Practice (GMP) Certification: Confirmed via audits by regulatory bodies such as the FDA, EMA, or equivalent authorities.
Certificate of Analysis (CoA): Detailed documentation verifying purity (>99%), enantiomeric excess, residual solvents, and contaminants.
Regulatory Compliance: Suppliers must adhere to USP, EP, or other pharmacopeias, with appropriate documentation for international markets.
Risk Mitigation: Diversification of suppliers reduces dependency risks, particularly given geopolitical and regulatory uncertainties.

Procurement Strategies and Market Dynamics

Pharmaceutical companies sourcing APIs for Azstarys must consider:

Supply Chain Security: Long-term agreements with multiple suppliers mitigate risks of shortages.
Cost Efficiency: Indian and Chinese APIs often provide cost advantages but require rigorous quality assurance.
Regulatory Alignment: Preference for suppliers with established GMP certifications aligned with target markets.
Intellectual Property (IP): Ensuring APIs are manufactured in a manner that respects patents and proprietary processes, especially given the complexity of serdexmethylphenidate synthesis.
Technology Transfer: Some manufacturers may seek licensed technology or proprietary synthesis methods from innovators to ensure consistent API quality.

Emerging Trends and Future Outlook

Vertical Integration: Large pharmaceutical companies increasingly invest in API manufacturing capacity to secure supply chains for complex entities like serdexmethylphenidate.
Biotechnological Production: While traditional chemical synthesis dominates current manufacturing, biotechnological methods may emerge, leveraging enzymatic processes for safer, more sustainable API production.
Regulatory Harmonization: Ongoing efforts by agencies like the ICH aim to streamline API standards and registration processes, facilitating global sourcing.
Sustainability and Green Chemistry: Suppliers adopting environmentally friendly synthesis processes will likely be favored, aligning with corporate sustainability goals.

Conclusion

The bulk sourcing of APIs for Azstarys involves a globally distributed network of manufacturers, primarily spanning the United States, India, and China. Ensuring the integrity, quality, and regulatory compliance of serdexmethylphenidate and dexmethylphenidate APIs remains paramount. Strategic procurement, diversification, and vigilant quality assurance underpin a reliable supply chain for this high-demand ADHD medication. As the pharmaceutical landscape evolves toward greater transparency and sustainability, API sourcing will continue adapting to meet both regulatory standards and market needs.

Key Takeaways

Diverse Global Suppliers: Consolidate relationships with reputable API manufacturers across key regions to mitigate supply chain risks.
Prioritize Quality Certifications: Ensure suppliers hold GMP certification and can provide comprehensive quality documentation.
Strategic Diversification: Rely on multiple suppliers, including domestic and international, to ensure continuity, cost management, and compliance.
Regulatory Vigilance: Maintain awareness of regional regulatory standards and adapt sourcing strategies accordingly.
Innovation and Sustainability: Monitor emerging manufacturing technologies and sustainable practices that could influence future API sourcing.

FAQs

1. Who are the leading API suppliers for methylphenidate derivatives used in Azstarys?

Leading suppliers include MilliporeSigma (USA), Aurobindo Pharma (India), Zhejiang Xinhua Pharmaceutical (China), and Hetero Labs (India). These firms provide GMP-compliant methylphenidate APIs suitable for pharmaceutical production.

2. What quality standards should API manufacturers meet for Azstarys?

Manufacturers must adhere to Good Manufacturing Practice (GMP), supply Certificates of Analysis (CoA), and comply with pharmacopeial standards such as USP or EP to ensure API purity, potency, and safety.

3. How does the geographical location of API manufacturing influence supply security?

Regional concentration poses risks like geopolitical disruptions or regulatory changes. Diversification among US, Indian, and Chinese suppliers enhances supply resilience and marketplace adaptability.

4. Are there regulatory hurdles when sourcing APIs from China or India for US-approved medications like Azstarys?

Yes, APIs from these regions must meet US FDA standards, with suppliers often undergoing audits and providing validation to ensure compliance with US regulations.

5. What technological trends are shaping the future of API sourcing for ADHD medications?

Emerging trends include biotechnological synthesis, green chemistry practices, and advanced manufacturing techniques aimed at improving sustainability, safety, and supply chain agility.

Sources:

[1] "API Market Analysis and Trends," India Brand Equity Foundation, 2022.
[2] "Global Pharmaceutical API Market," IQVIA, 2022.
[3] "Regulatory Guidelines for APIs," US FDA, 2023.
[4] "Chinese API Manufacturers," China Pharmaceutical Industry Association, 2022.
[5] "Innovations in API Production," International Federation of Pharmaceutical Manufacturers & Associations, 2022.

Bulk Pharmaceutical API Sources for AZSTARYS